Chronic Heart Failure Attenuates Oxytocin Signaling in the Central Amygdala

Lab / animal preprint OA: closed CC-BY-4.0
🔓 Open OA copy View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-15 ⓘ

Chronic heart failure in rats reduced oxytocin content and release in the central amygdala, downregulating oxytocin receptors and impairing oxytocin-driven GABAergic transmission.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Heart failure (HF) is often accompanied by cognitive and mood disturbances, yet the underlying neurobiological mechanisms remain unclear. Oxytocin (OT) signaling in the hypothalamus–amygdala axis, particularly within the central amygdala (CeA), is known to regulate mood and anxiety-like behaviors. Using an ischemic rat model of HF, we investigated whether altered OTergic signaling contributes to mood dysfunction. We found that CeA OTergic innervation primarily originates from the supraoptic nucleus (SON). Although SON→CeA OT neuron numbers were unchanged, OT content and release at CeA terminals were reduced, accompanied by downregulation of neuronal and astrocytic OT receptors and impaired OT receptor–driven GABAergic transmission. These findings reveal that HF disrupts hypothalamus-to-amygdala OTergic circuitry, suggesting that targeting OT signaling or amygdalar GABAergic function may help mitigate mood impairments in HF.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-08-12T06:43:03.944938+00:00
License: CC-BY-4.0